Table 8 Progress of hepatic encephalopathy in the studied groups at baseline and after 3, 6, 9 and 12 months of follow-up
Timing of hepatic encephalopathy | Number of episodes | Single infusion (Group I) | Repeated infusion (Group II) | Control group (Group III) | P value | |||
|---|---|---|---|---|---|---|---|---|
At baseline | No | 18 | 60 % | 17 | 56.7 % | 16 | 53.3 % | 0.9 |
Once | 5 | 16.7 % | 8 | 26.7 % | 9 | 30 % | ||
Repeated | 7 | 23.3 % | 5 | 16.7 % | 5 | 16.7 % | ||
Total | 30 | 100 % | 30 | 100 % | 30 | 100 % | ||
After 3 months | No | 28 | 93.3 % | 29 | 96.7 % | 26 | 86.7 % | 0.13 |
Once | 1 | 3.3 % | 1 | 3.3 % | 4 | 13.3 % | ||
Repeated | 0 | 0 % | 0 | 0 % | 0 | 0 % | ||
Mortality | 1 | 3.3 % | 0 | 0 % | 0 | 0 % | ||
Total | 30 | 100 % | 30 | 100 % | 30 | 100 % | ||
After 6 months | No | 25 | 83.3 % | 26 | 86.7 % | 23 | 76.7 % | |
Once | 3 | 10 % | 4 | 13.3 % | 6 | 20 % | ||
Repeated | 0 | 0 % | 0 | 0 % | 0 | 0 % | ||
Mortality | 2 | 6.7 % | 0 | 0 % | 1 | 3.3 % | ||
Total | 30 | 100 % | 30 | 100 % | 30 | 100 % | ||
After 9 months | No | 27 | 90 % | 27 | 90 % | 23 | 76.7 % | 0.37 |
Once | 1 | 3.3 % | 1 | 3.3 % | 5 | 16.7 % | ||
Repeated | 0 | 0 % | 2 | 6.7 % | 0 | 0 % | ||
Mortality | 2 | 6.7 % | 0 | 0 % | 2 | 6.7 % | ||
Total | 30 | 100 % | 30 | 100 % | 30 | 100 % | ||
After 12 months | No | 26 | 86.7 % | 25 | 83.3 % | 24 | 80 % | 0.47 |
Once | 1 | 3.3 % | 2 | 6.7 % | 1 | 3.3 % | ||
Twice | 0 | 0 % | 1 | 3.3 % | 0 | 0 % | ||
Mortality | 3 | 10 % | 2 | 6.7 % | 5 | 16.7 % | ||
Total | 30 | 100 % | 30 | 100 % | 30 | 100 % | ||